[
  {
    "ts": "2025-08-20T11:11:36+00:00",
    "headline": "PTC’s vatiquinone approval hopes dashed in Friedreich’s Ataxia",
    "summary": "The FDA has requested that PTC run an additional study to prove vatiquinone’s efficacy prior to resubmission.",
    "url": "https://www.pharmaceutical-technology.com/news/ptc-vatiquinone-fda-rejection-friedreich-ataxia/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "bfb13dbd-2af9-3a1f-99d3-a7ecb308f7df",
      "content": {
        "id": "bfb13dbd-2af9-3a1f-99d3-a7ecb308f7df",
        "contentType": "STORY",
        "title": "PTC’s vatiquinone approval hopes dashed in Friedreich’s Ataxia",
        "description": "",
        "summary": "The FDA has requested that PTC run an additional study to prove vatiquinone’s efficacy prior to resubmission.",
        "pubDate": "2025-08-20T11:11:36Z",
        "displayTime": "2025-08-20T11:11:36Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/943c4606ab1c22eb4a76a63171f84c1d",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "PTC Therapeutics' vatiquinone for Friedrich ataxia has been rejected by the FDA. \nImage credit: Piotr Swat / ShutterStock.com.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wMyrYEYMDhYorbwUrLrayQ--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/943c4606ab1c22eb4a76a63171f84c1d.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jI5vsF6rdvi.OWJnYtSoBQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/943c4606ab1c22eb4a76a63171f84c1d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/ptc-vatiquinone-fda-rejection-friedreich-ataxia/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ptc-vatiquinone-approval-hopes-dashed-111136598.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PTC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]